PDCD1 and neoplasm: In hepatocellular carcinoma, PD-L1 is primarily expressed on tumor cells, Kupffer cells, and hepatocytes, inhibiting T cell activity by binding to PD-1, thereby helping tumor cells evade immune system attacks.